271 related articles for article (PubMed ID: 26874244)
1. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
3. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
Liu ML; Zheng P; Liu Z; Xu Y; Mu J; Guo J; Huang T; Meng HQ; Xie P
Mol Biosyst; 2014 Jul; 10(9):2398-406. PubMed ID: 24975926
[TBL] [Abstract][Full Text] [Related]
4. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
5. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
6. Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study.
Liu ML; Zhang XT; Du XY; Fang Z; Liu Z; Xu Y; Zheng P; Xu XJ; Cheng PF; Huang T; Bai SJ; Zhao LB; Qi ZG; Shao WH; Xie P
J Transl Med; 2015 Jul; 13():226. PubMed ID: 26169624
[TBL] [Abstract][Full Text] [Related]
7. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression.
Li J; Tang G; Cheng K; Yang D; Chen G; Liu Z; Zhang R; Zhou J; Fang L; Fang Z; Du X; Xie P
Mol Biosyst; 2014 Nov; 10(11):2994-3001. PubMed ID: 25182291
[TBL] [Abstract][Full Text] [Related]
9. Plasma metabolome analysis of patients with major depressive disorder.
Kawamura N; Shinoda K; Sato H; Sasaki K; Suzuki M; Yamaki K; Fujimori T; Yamamoto H; Osei-Hyiaman D; Ohashi Y
Psychiatry Clin Neurosci; 2018 May; 72(5):349-361. PubMed ID: 29356314
[TBL] [Abstract][Full Text] [Related]
10. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
11. The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.
Ding X; Yang S; Li W; Liu Y; Li Z; Zhang Y; Li L; Liu S
PLoS One; 2014; 9(5):e97479. PubMed ID: 24870353
[TBL] [Abstract][Full Text] [Related]
12. Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.
Zheng P; Chen JJ; Zhou CJ; Zeng L; Li KW; Sun L; Liu ML; Zhu D; Liang ZH; Xie P
Transl Psychiatry; 2016 Nov; 6(11):e955. PubMed ID: 27845778
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of urinary metabolite biomarkers for major depressive disorder.
Zheng P; Wang Y; Chen L; Yang D; Meng H; Zhou D; Zhong J; Lei Y; Melgiri ND; Xie P
Mol Cell Proteomics; 2013 Jan; 12(1):207-14. PubMed ID: 23111923
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
Wang D; Cheng SL; Fei Q; Gu H; Raftery D; Cao B; Sun X; Yan J; Zhang C; Wang J
Psychiatry Res; 2019 Feb; 272():18-29. PubMed ID: 30579177
[TBL] [Abstract][Full Text] [Related]
16. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
[TBL] [Abstract][Full Text] [Related]
17. Identification of a biological signature for schizophrenia in serum.
Schwarz E; Guest PC; Rahmoune H; Harris LW; Wang L; Leweke FM; Rothermundt M; Bogerts B; Koethe D; Kranaster L; Ohrmann P; Suslow T; McAllister G; Spain M; Barnes A; van Beveren NJ; Baron-Cohen S; Steiner J; Torrey FE; Yolken RH; Bahn S
Mol Psychiatry; 2012 May; 17(5):494-502. PubMed ID: 21483431
[TBL] [Abstract][Full Text] [Related]
18. Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder.
He S; Liu X; Jiang K; Peng D; Hong W; Fang Y; Qian Y; Yu S; Li H
J Psychiatr Res; 2016 Jul; 78():65-71. PubMed ID: 27078210
[TBL] [Abstract][Full Text] [Related]
19. Differential urinary metabolites related with the severity of major depressive disorder.
Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
[TBL] [Abstract][Full Text] [Related]
20. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents.
Zhou X; Liu L; Lan X; Cohen D; Zhang Y; Ravindran AV; Yuan S; Zheng P; Coghill D; Yang L; Hetrick SE; Jiang X; Benoliel JJ; Cipriani A; Xie P
Mol Psychiatry; 2019 Oct; 24(10):1478-1488. PubMed ID: 29679072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
